Note: Ingredients listed on restricted chemical lists
EC/CAS
215-222-5/1314-13-2
Name of the chemical
Zinc oxide; C.I. 77947
Concentration
No.
EC/CAS
208-764-9/541-02-6
Name of the chemical
D5
Concentration
N/A
EC/CAS
63148-62-9
Name of the chemical
polydimethylsiloxane (Mw > 6 800 Da)
Concentration
N/A
EC/CAS
254-372-6/39236-46-9
Name of the chemical
N,N″-methylenebis[N′-[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]urea]
Concentration
<1 70-<80
General Information
Revision date
2018-05-06
Product name
SPECTRABAN 19
Product Synonyms
FORMULATION CODE 459A * STIEFEL PRODUCT * SPECTRABAN 19 (WITH 15% ZINC OXIDE) * ZINC OXIDE, FORMULATED PRODUCT
Icons in SDS
Company Information
company name
GlaxoSmithKline US
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
Section 2
EU Classification
Directive 67/548/EEC or 1999/45/EC as amended Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device. Regulation (EC) No 1272/2008 as amended Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device.
2.3 Other hazards
This product will support combustion at elevated temperatures. See section 11 for additional information on health hazards.
